Cargando…
Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria
Anaerobes play an important role in clinically relevant infections and resistance is increasing worldwide. We tested 120 rare anaerobic isolates belonging to 16 genera for antimicrobial resistance using the agar dilution method and compared those results to the time-saving E-test method. The suscept...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854874/ https://www.ncbi.nlm.nih.gov/pubmed/36671264 http://dx.doi.org/10.3390/antibiotics12010063 |
_version_ | 1784873236324941824 |
---|---|
author | Wolf, Lena Josephine Stingu, Catalina-Suzana |
author_facet | Wolf, Lena Josephine Stingu, Catalina-Suzana |
author_sort | Wolf, Lena Josephine |
collection | PubMed |
description | Anaerobes play an important role in clinically relevant infections and resistance is increasing worldwide. We tested 120 rare anaerobic isolates belonging to 16 genera for antimicrobial resistance using the agar dilution method and compared those results to the time-saving E-test method. The susceptibility data for 12 antimicrobial substances (benzylpenicillin, ampicillin/sulbactam, piperacillin/tazobactam, imipenem, meropenem, cefoxitin, metronidazole, moxifloxacin, clindamycin, doxycycline, tigecycline, eravacycline) were collected. Susceptibility testing showed low resistance to β-lactam/β-lactamase inhibitor combinations and no resistance to carbapenems and tigecycline. We observed moderate to high rates of resistance to moxifloxacin and clindamycin which differed depending on the methodology used. The essential and categorical agreement was over 90% for ampicillin/sulbactam, meropenem, moxifloxacin, and tigecycline. For metronidazole and clindamycin, the essential agreement was below 90% but the categorical agreement was near or above 90%. Penicillin presented with the lowest categorical agreement of 86.7% and a very high very major error rate of 13.3%. The resistance rates reported in this study are concerning and show the importance of routine susceptibility testing. Further investigations are necessary to determine the reason for high error rates and how to improve susceptibility testing of fastidious anaerobes. |
format | Online Article Text |
id | pubmed-9854874 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98548742023-01-21 Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria Wolf, Lena Josephine Stingu, Catalina-Suzana Antibiotics (Basel) Article Anaerobes play an important role in clinically relevant infections and resistance is increasing worldwide. We tested 120 rare anaerobic isolates belonging to 16 genera for antimicrobial resistance using the agar dilution method and compared those results to the time-saving E-test method. The susceptibility data for 12 antimicrobial substances (benzylpenicillin, ampicillin/sulbactam, piperacillin/tazobactam, imipenem, meropenem, cefoxitin, metronidazole, moxifloxacin, clindamycin, doxycycline, tigecycline, eravacycline) were collected. Susceptibility testing showed low resistance to β-lactam/β-lactamase inhibitor combinations and no resistance to carbapenems and tigecycline. We observed moderate to high rates of resistance to moxifloxacin and clindamycin which differed depending on the methodology used. The essential and categorical agreement was over 90% for ampicillin/sulbactam, meropenem, moxifloxacin, and tigecycline. For metronidazole and clindamycin, the essential agreement was below 90% but the categorical agreement was near or above 90%. Penicillin presented with the lowest categorical agreement of 86.7% and a very high very major error rate of 13.3%. The resistance rates reported in this study are concerning and show the importance of routine susceptibility testing. Further investigations are necessary to determine the reason for high error rates and how to improve susceptibility testing of fastidious anaerobes. MDPI 2022-12-29 /pmc/articles/PMC9854874/ /pubmed/36671264 http://dx.doi.org/10.3390/antibiotics12010063 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wolf, Lena Josephine Stingu, Catalina-Suzana Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria |
title | Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria |
title_full | Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria |
title_fullStr | Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria |
title_full_unstemmed | Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria |
title_short | Antimicrobial Susceptibility Profile of Rare Anaerobic Bacteria |
title_sort | antimicrobial susceptibility profile of rare anaerobic bacteria |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854874/ https://www.ncbi.nlm.nih.gov/pubmed/36671264 http://dx.doi.org/10.3390/antibiotics12010063 |
work_keys_str_mv | AT wolflenajosephine antimicrobialsusceptibilityprofileofrareanaerobicbacteria AT stingucatalinasuzana antimicrobialsusceptibilityprofileofrareanaerobicbacteria |